|
|
|
Volumn 41, Issue 1049, 1999, Pages 29-30
|
|
Lyme disease vaccine
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BORRELIA BURDORFERI VACCINE;
LYME DISEASE VACCINE;
UNCLASSIFIED DRUG;
VACCINE;
ADOLESCENT;
ADULT;
AGED;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FLU LIKE SYNDROME;
HUMAN;
HUMAN CELL;
HUMAN EXPERIMENT;
HUMAN TISSUE;
INJECTION PAIN;
INTRAMUSCULAR DRUG ADMINISTRATION;
LYME DISEASE;
MYALGIA;
NORMAL HUMAN;
RANDOMIZED CONTROLLED TRIAL;
SHORT SURVEY;
SYMPTOMATOLOGY;
VACCINATION;
ADOLESCENT;
ADULT;
AGED;
ANTI-BACTERIAL AGENTS;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
INJECTIONS, INTRAMUSCULAR;
LYME DISEASE;
MIDDLE AGED;
NORTH AMERICA;
RANDOMIZED CONTROLLED TRIALS;
SEASONS;
VACCINES, SYNTHETIC;
|
|
EID: 0033605724
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (10)
|
|
References (0)
|